Skip to main content

Advertisement

SpringerLink
Log in

Applicability of Dynamic Risk Stratification for Differentiated Thyroid Cancer (DTC) in a Resource Limited Setting

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Dynamic risk stratification (DRS) in DTC has been considered necessary to deliver correct follow-up (FU) treatment, avoiding overtreatment of low risk/intermediate risk patients as well as inadequate treatment of high risk patients. However, it’s clinical applicability has been questioned in comparison with more conventional FU protocols. We aimed to know the predictive reliability of DRS in monitoring FU of DTC in a resource-constrained setting across various risk groups, especially when compared with clinical examination alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Unnikrishnan AG, Menon UV (2011) Thyroid disorders in India: an epidemiological perspective. Indian J Endocr Metab 15(Suppl S2):78–81

    Article  Google Scholar 

  2. Omry-Orbach G (2016) Risk stratification in differentiated thyroid cancer: an ongoing process. Rambam Maimonides Med J 7(1):e0003. https://doi.org/10.5041/rmmj.10230

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shah JP (2015) Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin Adv Hematol Oncol 13(4 Suppl 4):3–6

    PubMed  PubMed Central  Google Scholar 

  4. Cooper DS, Doherty GM et al (2009) American thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214. https://doi.org/10.1089/thy.2009.0110

    Article  PubMed  Google Scholar 

  5. Vaisman F, Momesso D, Bulzico DA et al (2012) Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clin Endocrinol (Oxf) 77:132–138. https://doi.org/10.1111/j.1365-2265.2012.04342.x

    Article  CAS  PubMed  Google Scholar 

  6. Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803. https://doi.org/10.1530/eje.1.02158

    Article  CAS  PubMed  Google Scholar 

  7. Shaha AR (2004) Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 3:393–402

    Article  Google Scholar 

  8. Vaisman F, Tala H, Grewal R, Tuttle RM (2011) In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21:1317–1322

    Article  CAS  PubMed  Google Scholar 

  9. Haugen BR, Alexander EK, Bible KC et al (2016) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020

    Article  PubMed  PubMed Central  Google Scholar 

  10. Momesso D, Vaisman F, Yang SP, Bulzico D, Corbo R, Vaisman M, Michael Tuttle R (2016) Dynamic risk stratification in differentiated thyroid cancer patients treated without radioactive iodine. J Clin Endocrinol Metab 101:jc20154290. https://doi.org/10.1210/jc.2015-4290

    Article  CAS  Google Scholar 

  11. Amoako-Tuffour Y, Graham ME, Bullock M et al (2017) Papillary thyroid cancer recurrence 43 years following total thyroidectomy and radioactive iodine ablation: a case report. Thyroid Res 10:8. https://doi.org/10.1186/s13044-017-0043-4

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cho BY, Choi HS, Park YJ et al (2013) Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 23(7):797–804

    Article  PubMed  PubMed Central  Google Scholar 

  13. Schlumberger M, Pacini F, Wiersinga WM et al (2004) Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 151:539–548

    Article  CAS  PubMed  Google Scholar 

  14. Jeon MJ, Kim WG, Park WR et al (2014) Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma. Eur J Endocrinol 170:23–30

    Article  CAS  PubMed  Google Scholar 

  15. Kowalska A, Walczyk A, Pałyga I et al (2016) The delayed risk stratification system in the risk of differentiated thyroid cancer recurrence. PLoS ONE. 11(4):e0153242. https://doi.org/10.1371/journal.pone.0153242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Morosán YJ, Parisi C, Urrutia MA, Rosmarin M, Schnitman M, Serrano L et al (2016) Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma. Arch Endocrinol Metab 60(4):348–354. https://doi.org/10.1590/2359-3997000000146

    Article  PubMed  Google Scholar 

  17. Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94:692–700

    Article  PubMed  Google Scholar 

  18. Durante C, Montesano T, Attard M et al (2012) Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? J Clin Endocrinol Metab 97:2748–2753

    Article  CAS  PubMed  Google Scholar 

  19. Yoon JH, Han K, Kim EK, Moon HJ, Kwak JY (2017) Diagnosis and management of small thyroid nodules: a comparative study with six guidelines for thyroid nodules. Radiology 283(2):560–569. https://doi.org/10.1148/radiol.2016160641

    Article  PubMed  Google Scholar 

  20. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH et al (2011) Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260:892–899

    Article  PubMed  Google Scholar 

  21. Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A (2010) Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system. Thyroid 20(12):1341–1349

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tuttle RM (2008) Risk-adapted management of thyroid cancer. Endocr Pract 14:764–774. https://doi.org/10.4158/EP.14.6.764

    Article  PubMed  Google Scholar 

  23. Tuttle RM, Leboeuf R, Shaha AR (2008) Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol 97:712–716. https://doi.org/10.1002/jso.21010

    Article  PubMed  Google Scholar 

  24. Castagna MG, Maino F, Cipri C et al (2011) Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome productivity in differentiated thyroid cancer patients. Eur J Endocrinol 165:441–446. https://doi.org/10.1530/EJE-11-0466

    Article  CAS  PubMed  Google Scholar 

  25. Hong CM, Lee WK, Jeong SY, Lee SW, Ahn BC, Lee J (2014) Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation. Nucl Med Commun 35:1119–1126. https://doi.org/10.1097/MNM.0000000000000183

    Article  CAS  PubMed  Google Scholar 

  26. Bal C, Ballal S, Soundararajan R, Chopra S, Garg A (2015) Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment. Cancer Med 4(7):1031–1038

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of ENT, ESIC Medical College Hospital, Hyderabad, Telangana, India

    Karthik Munagala, S. Vijay Praveen & Sanjay Kishve

  2. Sunshine Hospital, Hyderabad, Telangana, India

    Keerthana Maadam

  3. Department of HNS, Patel Hospital, Jalandhar, Punjab, India

    Shamit Chopra

Authors
  1. Karthik Munagala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Vijay Praveen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keerthana Maadam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shamit Chopra
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sanjay Kishve
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karthik Munagala.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All the procedures performed in studies involving human participants were in accordance with institutional ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Munagala, K., Vijay Praveen, S., Maadam, K. et al. Applicability of Dynamic Risk Stratification for Differentiated Thyroid Cancer (DTC) in a Resource Limited Setting. Indian J Otolaryngol Head Neck Surg 74 (Suppl 2), 2217–2221 (2022). https://doi.org/10.1007/s12070-020-02069-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-020-02069-4

Keywords

Search

Navigation